FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. - Wikidata - awgldk - TriplyDB

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.

http://www.wikidata.org/entity/Q34518185

about

Microbiome, Metabolome and Inflammatory Bowel Disease May the Force Be With You: The Light and Dark Sides of the Microbiota-Gut-Brain Axis in Neuropsychiatry.Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance.A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.Controversies and Recent Developments of the Low-FODMAP Diet.New insights in IBS-like disorders: Pandora's box has been opened; a review The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis The role of fermentable carbohydrates and beverages in the symptomatology of functional gastrointestinal disease.Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.Inaccuracy of patient-reported descriptions of and satisfaction with bowel actions in irritable bowel syndrome.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?"We are what our bacteria eat": The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions.Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies.Nutritional, microbiological and psychosocial implications of the low FODMAP diet.Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.Proteomics and irritable bowel syndrome.Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs A GWAS meta-analysis suggests roles for xenobiotic metabolism and ion channel activity in the biology of stool frequency Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating.Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.Fructans Exacerbate Symptoms in a Subset of Children With Irritable Bowel Syndrome.Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions.Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team?Existing and emerging therapies for managing constipation and diarrhea.Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.Does a low FODMAPs diet reduce symptoms of functional abdominal pain disorders? A systematic review in adult and paediatric population, on behalf of Italian Society of Pediatrics.Role of the gut microbiota in nutrition and health.The gut microbiome and irritable bowel syndrome.A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults

P2860

Q28078126-3D742955-8026-4C5D-9F05-C53EDBEB3B09 Q30489570-29F1C1AE-95D6-4334-AD3F-C4DFC575EE48 Q33469889-421CD013-4F81-4CE0-9A52-A34601887549 Q33470900-8665B579-AF72-410A-97CA-97CD26B5A477 Q33560187-7FA47803-C00F-465C-B772-066295A46CDC Q33867365-02920C3B-B0D4-43C5-AEB6-7EA09BE1D2F9 Q37729859-731CB163-C5A6-4CF6-A2D6-8C4211C066C9 Q38605779-3D96DE51-0D96-48EA-8A68-A533E9C6CD04 Q38616020-6E554DA2-014A-4DB5-B655-088B26F9D56E Q38625807-816D616D-CF0B-4E9B-B6D8-FFB1BB2C5A72 Q38629237-1A83CB33-21EC-4F6A-806C-0FAE0240FE3F Q38765085-1CE4A218-15CF-4DB4-933E-3168C86CA770 Q38850023-4C2F2325-7F65-4463-875D-1BBD0031BC0F Q38874396-61B74FB5-641B-490A-9B7D-993D28F0B5BB Q38937580-69F8035E-E3F5-4B71-AEDC-90BD48246FE8 Q38981245-C71BD1F6-43B3-41E1-A70A-1EDD285EF004 Q39058964-090F0730-FC62-488D-9F75-667A3A290F21 Q39166000-CD7014E5-2F0D-4E6C-8467-B11C394B13F2 Q39170157-52980B7B-8BDC-46AE-986A-7FBFAC01BD82 Q39232397-306D1913-5179-45DE-A671-A0205FF4631B Q39261094-C122E705-8F8A-456D-8EA4-F5726F9923D9 Q39334633-E94FD37C-BAB6-479B-9390-B0737DF117EB Q40976092-6CD34787-7949-4B38-92A8-47B20423D3D8 Q42337989-AC50FD00-1FE9-4888-AE49-46CC6D9FF921 Q42338503-C38F7245-146D-4C64-9152-8A85062DD0AE Q42375222-97D08339-260B-4AAE-91C7-29F4558E4A24 Q47112614-A13E7BAA-245F-465F-897B-F1800AA5E74C Q47752088-7ABF4401-AEA1-4D29-8797-20ABBC46A755 Q47779360-B17C03EC-7AC9-4D77-B5AF-A36EC65036DE Q47801593-A1CA9560-E6AD-4D9C-924B-962297A92330 Q47864147-DF91ADC4-CE47-4C8E-BA64-60BFE51B14CE Q48288738-A21D6D29-675B-4531-9CA0-C38A1C0F4485 Q49677641-C6A5298B-9B8D-4306-87E4-F7611D51FC58 Q49985626-A91EE78F-ABCE-4B58-9930-55A17ACEB201 Q52312388-2068DB2F-0DCD-44D6-81F6-966BA8A523E0 Q55220302-2A818DCB-D6E8-4FF2-9886-726D9E5A330B Q55383691-E25A6C82-D8D2-40D2-AE45-87F5D4D8875F Q55716608-8FB3D091-B7A6-4F51-A215-AFC873FB1EDE Q58800472-A6A6B57C-D081-4978-9126-021393E5E5AC Q59132684-03349DF1-5244-4AB0-83C4-A71086D43D82

P2860

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.

http://www.wikidata.org/entity/Q34518185

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@ast

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@en

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@nl

type

label

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@ast

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@en

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@nl

prefLabel

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@ast

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@en

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@nl

P1433

Q34518185-9DC606BC-1A2B-4FC0-A818-3ABAC0CB5718

P1476

Q34518185-83E6978C-F56B-4F38-BE98-340EC6F8646D

P2093

Q34518185-2CA1E285-FD18-4431-BE08-BF468CCC8356

Q34518185-59548618-96BB-48BB-9EFB-2D28EBBB46F7

Q34518185-62EAF202-8F5C-47FA-BA5B-472DA8E1EBEC

Q34518185-6BB5E045-971D-4224-A0ED-35CAF011A8E7

Q34518185-70B1802C-5D75-46E2-A75B-86C0A336776D

Q34518185-E572D205-12D2-41D2-8ED6-349FB87F2476

Q34518185-FB1FC60F-AD5E-46EC-95B5-CCAE285E4651

Q34518185-FF107A45-350D-427E-A3DD-999C01E5AEDC

P304

Q34518185-2E3F6262-4936-48DF-8BEC-CCA84DD3F108

P31

Q34518185-08C44DDF-38AB-42A1-AB44-CA72E5745582

P356

Q34518185-B35907A6-1B96-419D-9129-95404CCBFB4E

P407

Q34518185-0182BFF1-B150-4FA8-8858-70B7351C9286

P433

Q34518185-34F4D968-5EA6-4B2A-BE5D-40F8D9D4C63B

P478

Q34518185-0B51B3DE-8A7D-4836-B6D6-3924DA3484AC

P50

Q34518185-FBC682C6-E70B-485A-A737-CF6A476A86B7

P577

Q34518185-E7A76D53-F278-42DC-93AE-5428CB19DF2C

P5875

Q34518185-68915665-7EA1-4B13-87D8-8A150C3327EC

P698

Q34518185-E61AE5E9-CB53-4CC4-BD23-E8A51BE73AC5

P921

Q34518185-4C2CE450-52C3-47AF-8D84-97C8E66EC8B8

P356

GUTJNL-2015-311339

P1433

P1476

FODMAPs alter symptoms and the ...... a randomised controlled trial.

@en

P2093

Ammar H Keshteli

http://www.w3.org/2001/XMLSchema#string

David E Reed

http://www.w3.org/2001/XMLSchema#string

Frances Dang

http://www.w3.org/2001/XMLSchema#string

Karen Madsen

http://www.w3.org/2001/XMLSchema#string

Keith McIntosh

http://www.w3.org/2001/XMLSchema#string

Premysl Bercik

http://www.w3.org/2001/XMLSchema#string

Stephen Vanner

http://www.w3.org/2001/XMLSchema#string

Theresa Schneider

http://www.w3.org/2001/XMLSchema#string

P304

1241-1251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2015-311339

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298423295

http://www.w3.org/2001/XMLSchema#string

P698

26976734

http://www.w3.org/2001/XMLSchema#string

P921